ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Clearpoint Neuro Inc. (CLPT) PT Raised to $9 at Stifel
March 13, 2024 4:35 AM EDTStifel analyst Mathew Blackman raised the price target on Clearpoint Neuro Inc. (NASDAQ: CLPT) to $9.00 (from $8.00) while maintaining a Buy rating.
The analyst comments "Closing the book on 2023 with 17% topline growth and significant reduction in cash burn, CLPT has already garnered considerable momentum... More
